Product Details:
| Minimum Order Quantity | 10 Pack |
| Strength | 5 mg |
| Packaging Size | 30*10 Tablets |
| Packaging Type | Box |
| Brand | Apigat |
| Manufacturer | NATCO |
| Usage | To treat and prevent blood clots |
| Country of origin | Made in india |
| COMPOSITION | APIXABAN 5 MG |
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Box |
| Strength | 15 mg |
| Country of Origin | Made in India |
| Usage | Medical |
| Form | Tablet |
| Brand | Xarelto |
Additional Information:
Product Details:
| Minimum Order Quantity | 10 Strip |
| Strength | 10 mg |
| Packaging Size | 7 tablets |
| Composition | RIVAROXABAN 10 mg Tablet |
| Manufacture By | Bayer Zydus Pharma |
| Country of Origin | Made in India |
💊 What is Xarelto (Rivaroxaban) 10 mg?
Xarelto is the brand name for Rivaroxaban, a direct oral anticoagulant (DOAC). The 10 mg tablet is typically used to prevent blood clots (deep vein thrombosis or DVT) especially after surgeries like knee or hip replacement.
🔬 Drug Class:Anticoagulant
Direct Factor Xa Inhibitor
Rivaroxaban works by:
Inhibiting Factor Xa, an essential enzyme in the coagulation cascade
This prevents the formation of thrombin, a key substance needed to form clots
As a result, it helps prevent or treat blood clots in veins or arteries
Unlike older anticoagulants (like warfarin), Rivaroxaban works without requiring routine blood monitoring.
🩺 Uses of Xarelto 10 mg:| Condition | Use |
|---|---|
| Postoperative DVT prophylaxis | After hip or knee replacement surgery |
| Prevention of venous thromboembolism (VTE) | Especially in high-risk patients |
| May be used off-label or in certain regions for DVT/PE treatment after initial higher dose (e.g. 15 mg, then 10 mg) |
Note: For atrial fibrillation, DVT treatment, or stroke prevention, higher doses (15 mg or 20 mg) are typically used.
📏 Dosage of 10 mg Tablet:| Situation | Typical Dose |
|---|---|
| After knee replacement surgery | 10 mg once daily for 12 days |
| After hip replacement surgery | 10 mg once daily for 35 days |
| General VTE prevention | As directed (often 10 mg daily) |
Take with or without food. For higher doses (15/20 mg), take with food.
💊 Drug Interactions:Other anticoagulants/antiplatelets (e.g. aspirin, clopidogrel) → increased bleeding risk
NSAIDs (ibuprofen, diclofenac) → increased bleeding risk
Rifampicin, phenytoin, carbamazepine → reduce rivaroxaban levels (less effective)
Azole antifungals, ritonavir → increase rivaroxaban levels (risk of bleeding)
Fixed dosing (no routine INR monitoring like warfarin)
Rapid onset of action
Convenient oral tablet
Shorter half-life compared to warfarin
Missed dose: Take as soon as possible the same day. Skip if it's almost time for the next dose.
Overdose: Can lead to life-threatening bleeding—seek emergency care.
Surgery: Must be stopped in advance to reduce bleeding risk—follow doctor’s guidance.
Xarelto (by Bayer)
Generic Rivaroxaban also available under various brands depending on country
| Feature | Details |
|---|---|
| Generic Name | Rivaroxaban |
| Brand Name | Xarelto |
| Strength | 10 mg |
| Use | Prevent blood clots (DVT) after surgery |
| Type | Direct oral anticoagulant (Factor Xa inhibitor) |
| Main Risk | Bleeding |
| Monitoring | Usually not required |
| Route | Oral tablet |
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Box |
| Strength | 2.5 mg |
| Packaging Type | Box |
| Brand | Apigat |
| Manufacturer | Natco |
| Shelf life | 36 months |
| Usage | To treat and prevent blood clots |
| Country of origin | Made in india |
Uses of Apixaban 2.5 mg Tablet:
Apixaban is an oral anticoagulant (blood thinner) belonging to the class of Factor Xa inhibitors. It helps prevent blood clots from forming or growing larger by blocking Factor Xa, a key enzyme in the blood clotting process.
🔹 Therapeutic Uses:
Prevention of Stroke and Systemic Embolism
In patients with non-valvular atrial fibrillation (AF) — irregular heartbeat that increases stroke risk.
Prevention of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)
After hip or knee replacement surgery, to reduce risk of post-surgical clots.
Treatment of DVT and PE
Used to treat existing blood clots in legs or lungs and prevent recurrence.
Secondary Prevention of DVT and PE
Long-term therapy to prevent recurrence after initial treatment phase.
Usually taken twice daily, with or without food.
Do not stop suddenly without medical advice — stopping abruptly increases risk of clot formation.
Avoid concurrent use with other anticoagulants or NSAIDs unless prescribed.
Bleeding is the main side effect; seek immediate help if there’s unusual bruising, blood in urine/stool, or prolonged bleeding.
Dose adjustment may be needed in elderly, low-weight, or kidney-impaired patients.
Additional Information: